Investing
Emergent BioSolutions to lay off about 400 employees
© Reuters. FILE PHOTO: A nurse demonstrates the application of the NARCAN nasal spray medication at a outpatient treatment center in Indiana, Pennsylvania, U.S. August 9, 2017. Picture taken August 9, 2017. REUTERS/Adrees Latif/File Photo
(Reuters) – Emergent BioSolutions Inc said on Tuesday it plans to lay off about 400 employees across all businesses and cut back operations at some of its facilities.
The company added that it will reduce operations at its Bayview facility in Baltimore and the facility in Canton, Massachusetts.
Emergent will focus on its core products business of medical countermeasures and its overdose reversal nasal spray Narcan, the company said, adding that it will also do away with the chief operating officer role.
Read the full article here
-
Investing5 days ago
This All-Access Pass to Learning Is Now $20 for Black Friday
-
Passive Income5 days ago
How to Create a Routine That Balances Rest and Business Success
-
Side Hustles6 days ago
Apple Prepares a New AI-Powered Siri to Compete With ChatGPT
-
Side Hustles3 days ago
A Macy’s Employee Made Accounting Errors Worth $132 Million
-
Passive Income6 days ago
Customers Want More Than Just a Product — Here’s How to Keep Up
-
Investing2 days ago
Factbox-How Trump can overhaul US financial regulators when he takes office By Reuters
-
Side Hustles7 days ago
MIT Gives Free Tuition For Families Earning $200,000 or Less
-
Side Hustles5 days ago
Gift the Power of Language Learning with This Limited-Time Price on Babbel